Results 281 to 290 of about 734,043 (307)

Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine

European Neuropsychopharmacology, 2001
J.A. Gilmore, L. Wang, B.J. Kinon
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

P.445 Dose-response relationships of antipsychotic drugs for major depressive disorder: a systematic review and meta-analysis

European Neuropsychopharmacology, 2020
Christoph U. Correll, Katsuhiko Hagi, S. Kurokawa, Taishiro Kishimoto, John M. Kane   +4 more
openaire   +2 more sources

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Nabil F Saba
exaly  

Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate ?sensitization? to ?drug wanting??

Psychopharmacology, 2004
Ekkehard Madlung, Gudrun Wakonigg, Gerald Zernig, Alois Saria, C. Haring   +4 more
openaire   +3 more sources

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
Aasha I Hoogland, Naomi C Brownstein, Adam P Dicker   +2 more
exaly  

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly